1. Home
  2. GHLD vs TVTX Comparison

GHLD vs TVTX Comparison

Compare GHLD & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHLD
  • TVTX
  • Stock Information
  • Founded
  • GHLD 1960
  • TVTX 2008
  • Country
  • GHLD United States
  • TVTX United States
  • Employees
  • GHLD N/A
  • TVTX N/A
  • Industry
  • GHLD Finance: Consumer Services
  • TVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GHLD Finance
  • TVTX Health Care
  • Exchange
  • GHLD Nasdaq
  • TVTX Nasdaq
  • Market Cap
  • GHLD 1.0B
  • TVTX 1.1B
  • IPO Year
  • GHLD 2020
  • TVTX N/A
  • Fundamental
  • Price
  • GHLD $15.44
  • TVTX $18.25
  • Analyst Decision
  • GHLD Buy
  • TVTX Buy
  • Analyst Count
  • GHLD 5
  • TVTX 13
  • Target Price
  • GHLD $17.50
  • TVTX $20.85
  • AVG Volume (30 Days)
  • GHLD 16.0K
  • TVTX 2.5M
  • Earning Date
  • GHLD 11-06-2024
  • TVTX 11-05-2024
  • Dividend Yield
  • GHLD 3.19%
  • TVTX N/A
  • EPS Growth
  • GHLD N/A
  • TVTX N/A
  • EPS
  • GHLD 0.44
  • TVTX N/A
  • Revenue
  • GHLD $913,919,000.00
  • TVTX $177,644,000.00
  • Revenue This Year
  • GHLD $57.72
  • TVTX $58.99
  • Revenue Next Year
  • GHLD $14.50
  • TVTX $53.18
  • P/E Ratio
  • GHLD $35.49
  • TVTX N/A
  • Revenue Growth
  • GHLD 15.69
  • TVTX 47.42
  • 52 Week Low
  • GHLD $9.59
  • TVTX $5.12
  • 52 Week High
  • GHLD $18.26
  • TVTX $18.81
  • Technical
  • Relative Strength Index (RSI)
  • GHLD 42.28
  • TVTX 74.30
  • Support Level
  • GHLD $14.89
  • TVTX $16.17
  • Resistance Level
  • GHLD $15.90
  • TVTX $18.60
  • Average True Range (ATR)
  • GHLD 0.45
  • TVTX 1.24
  • MACD
  • GHLD -0.10
  • TVTX 0.17
  • Stochastic Oscillator
  • GHLD 30.73
  • TVTX 89.95

About GHLD Guild Holdings Company

Guild Holdings Co is a growth-oriented mortgage company. It operates in two segments; The origination segment operates its loan origination business throughout the United States. It is responsible for loan origination, acquisition, and sale activities. This segment is further divided into retail and correspondent channel, and The servicing segment provides a steady stream of cash flow to support the origination segment more importantly it allows for the Company to build long-standing client relationships that drive repeat and referral business back to the origination segment to recapture the client's next mortgage transaction. It is responsible for the servicing activities of all loans in its servicing portfolio. It generates a majority of its revenue from the Origination segment.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: